Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro-oncology. 2018;20:iv1–iv86.
Article
Google Scholar
Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, et al. Effect of tumor-treating fields plus maintenance Temozolomide vs maintenance Temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 2017;318(23):2306–16. https://doi.org/10.1001/jama.2017.18718.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang B, Zhang H, Gu L, Ye B, Jian Z, Stary C, et al. Advances in immunotherapy for glioblastoma Multiforme. J Immunol Res. 2017;3597613:1–11. https://doi.org/10.1155/2017/3597613.
Article
CAS
Google Scholar
Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev. 2008;18(1):11–8. https://doi.org/10.1016/j.gde.2007.12.007.
Article
CAS
PubMed
PubMed Central
Google Scholar
Engelhard VH, Rodriguez AB, Mauldin IS, Woods AN, Peske JD, Slingluff CL. Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity. J Immunol. 2018;200(2):432–42. https://doi.org/10.4049/jimmunol.1701269.
Article
CAS
PubMed
Google Scholar
Germain C, Gnjatic S, Dieu-Nosjean MC. Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity. Front Immunol. 2015;6:67. https://doi.org/10.3389/fimmu.2015.00067.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lohr J, Ratliff T, Huppertz A, Ge Y, Dictus C, Ahmadi R, et al. Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res. 2011;17(13):4296–308. https://doi.org/10.1158/1078-0432.CCR-10-2557.
Article
CAS
PubMed
Google Scholar
Yang I, Tihan T, Han SJ, Wrensch MR, Wiencke J, Sughrue ME, et al. CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci. 2010;17(11):1381–5. https://doi.org/10.1016/j.jocn.2010.03.031.
Article
PubMed
PubMed Central
Google Scholar
Kmiecik J, Poli A, Brons NHC, Waha A, Eide GE, Enger PØ, et al. Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J Neuroimmunol. 2013;264(1-2):71–83. https://doi.org/10.1016/j.jneuroim.2013.08.013.
Article
CAS
PubMed
Google Scholar
Madkouri R, Kaderbhai CG, Bertaut A, Truntzer C, Vincent J, Aubriot-Lorton MH, et al. Immune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma. Oncoimmunology. 2017;6(6):e1321186. https://doi.org/10.1080/2162402X.2017.1321186.
Article
PubMed
PubMed Central
Google Scholar
Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature. 2019;565(7738):240–5. https://doi.org/10.1038/s41586-018-0810-y.
Article
CAS
PubMed
Google Scholar
Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2019;565(7738):234–9. https://doi.org/10.1038/s41586-018-0792-9.
Article
CAS
PubMed
Google Scholar
Brown NF, Carter TJ, Ottaviani D, Mulholland P. Harnessing the immune system in glioblastoma. Br J Cancer. 2018;119(10):1171–81. https://doi.org/10.1038/s41416-018-0258-8.
Article
PubMed
PubMed Central
Google Scholar
Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-oncology. 2006;8(3):261–79. https://doi.org/10.1215/15228517-2006-008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Orrego E, Castaneda CA, Castillo M, Bernabe LA, Casavilca S, Chakravarti A, et al. Distribution of tumor-infiltrating immune cells in glioblastoma. CNS Oncol. 2018;7(4):CNS21. https://doi.org/10.2217/cns-2017-0037.
Article
CAS
PubMed
PubMed Central
Google Scholar
Candolfi M, Curtin JF, Yagiz K, Assi H, Wibowo MK, Alzadeh GE, et al. B cells are critical to T-cell—mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma. Neoplasia. 2011;13(10):947–IN23. https://doi.org/10.1593/neo.11024.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chu AB, Sever JL, Madden DL, Livanainen M, Leon M, Wallen W, et al. Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann Neurol. 1983;13:434–9.
Article
CAS
Google Scholar
Zhu VF, Yang J, Lebrun DG, Li M. Understanding the role of cytokines in glioblastoma Multiforme pathogenesis. Cancer Lett. 2012;316(2):139–50. https://doi.org/10.1016/j.canlet.2011.11.001.
Article
CAS
PubMed
Google Scholar
Hori T, Sasayama T, Tanaka K, Koma YI, Nishihara M, Tanaka H, et al. Tumor-associated macrophage related interleukin-6 in cerebrospinal fluid as a prognostic marker for glioblastoma. J Clin Neurosci. 2019;68:281–9. https://doi.org/10.1016/j.jocn.2019.07.020.
Article
CAS
PubMed
Google Scholar
DeCordova S, Shastri A, Tsolaki AG, Yasmin H, Klein L, Singh SK, et al. Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma. Front Immunol. 2020;11:1402. https://doi.org/10.3389/fimmu.2020.01402.
Article
CAS
PubMed
PubMed Central
Google Scholar
Murray PJ. Macrophage Polarization. Ann Rev Physiol. 2017;79:541–66.
Article
CAS
Google Scholar
Zeiner PS, Preusse C, Golebiewska A, Zinke J, Iriondo A, Muller A, et al. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Brain Pathol. 2019;29(4):513–29. https://doi.org/10.1111/bpa.12690.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vidyarthi A, Agnihotri T, Khan N, Singh S, Tewari MK, Radotra BD, et al. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity. Cancer Immunol. 2019;68(12):1995–2004. https://doi.org/10.1007/s00262-019-02423-8.
Article
CAS
Google Scholar
Mignogna C, Signorelli F, Vismara MF, Zeppa P, Camastra C, Barni T, et al. A reappraisal of macrophage polarization in glioblastoma: histopathological and immunohistochemical findings and review of the literature. Pathol Res Pract. 2016;212(6):491–9. https://doi.org/10.1016/j.prp.2016.02.020.
Article
CAS
PubMed
Google Scholar
Zhai H, Heppner FL, Tsirka SE. Microglia/macrophages promote glioma progression. Glia. 2011;59(3):472–85. https://doi.org/10.1002/glia.21117.
Article
PubMed
Google Scholar
Quillien V, Lavenu A, Ducray F, Joly MO, Chinot O, Fina F, et al. Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial. Oncotarget. 2016;7(38):61916–29. https://doi.org/10.18632/oncotarget.11322.
Article
PubMed
PubMed Central
Google Scholar
Domingues P, González-Tablas M, Otero Á, Pascual D, Miranda D, Ruiz L, et al. Tumor infiltrating immune cells in gliomas and meningiomas. Brain Behav Immunity. 2016;53:1–15.
Article
CAS
Google Scholar
Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J, Kiyose M, et al. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases. Oncotarget. 2015;6(38):40836–49. https://doi.org/10.18632/oncotarget.5696.
Article
PubMed
PubMed Central
Google Scholar
Lepennetier G, Hracsko Z, Unger M, van Griensven M, Grummel V, Krumbholz M, et al. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases. J Neuroinflammation. 2019;16:219.
Article
CAS
Google Scholar
Balik V, Mirossay P, Bohus P, Sulla I, Mirossay L, Sarissky M. Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy. Cell Mol Neurobiol. 2009;29(6-7):845–58. https://doi.org/10.1007/s10571-009-9366-6.
Article
CAS
PubMed
Google Scholar
Pinton L, Masetto E, Vettore M, Solito S, Magri S, D'Andolfi M, et al. The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. J Immunother Cancer. 2019;7(1):58. https://doi.org/10.1186/s40425-019-0536-x.
Article
PubMed
PubMed Central
Google Scholar
Kowarik MC, Cepok S, Sellner J, Grummel V, Weber MS, Korn T, et al. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation. 2012;9(1):93. https://doi.org/10.1186/1742-2094-9-93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schlößer HA, Thelen M, Lechner A, Wennhold K, Garcia-Marquez MA, Rothschild SI, et al. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies. Oncoimmunology. 2019;8(1):e1512458. https://doi.org/10.1080/2162402X.2018.1512458.
Article
PubMed
Google Scholar
Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, et al. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. PLoS One. 2014;9(6):e99008. https://doi.org/10.1371/journal.pone.0099008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yamakoshi Y, Tanaka H, Sakimura C, Deguchi S, Mori T, Tamura T, et al. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer. Int J Oncol. 2020;57(1):171–82. https://doi.org/10.3892/ijo.2020.5042.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311–36. https://doi.org/10.1007/s00401-018-1815-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brandenburg S, Müller A, Turkowski K, Radev YT, Rot S, Schmidt C, et al. Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors. Acta Neuropathol. 2016;131(3):365–78. https://doi.org/10.1007/s00401-015-1529-6.
Article
CAS
PubMed
Google Scholar
Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, et al. Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens. Oncotarget. 2017;8(7):10785–808. https://doi.org/10.18632/oncotarget.13911.
Article
PubMed
Google Scholar
Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A. 2001;98(15):8732–7. https://doi.org/10.1073/pnas.161126098.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao J, Zhao L, Wan YY, Zhu B. Mechanism of action of IL-7 and its potential applications and limitations in Cancer immunotherapy. Int J Mol Sci. 2015;16(12):10267–80. https://doi.org/10.3390/ijms160510267.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fritzell S, Eberstål S, Sandén E, Visse E, Darabi A, Siesjö P. IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models. J Neuroimmunol. 2013;258(1-2):91–5. https://doi.org/10.1016/j.jneuroim.2013.02.017.
Article
CAS
PubMed
Google Scholar
Shan Y, He X, Song W, Han D, Niu J, Wang J. Role of IL-6 in the invasiveness and prognosis of glioma. Int J Clin Exp Med. 2015;8(6):9114–20.
PubMed
PubMed Central
Google Scholar
Vera S, Sinning M, Vergara M, Lemus D, Rosas C. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study. J Neuro-Oncol. 2019;145(2):233–9. https://doi.org/10.1007/s11060-019-03314-9.
Article
CAS
Google Scholar
Sampath P, Weaver CE, Sungarian A, Cortez S, Alderson L, Stopa EG. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma. Cancer Control. 2004;11(3):174–80. https://doi.org/10.1177/107327480401100305.
Article
PubMed
Google Scholar
Peles E, Lidar Z, Simon AJ, Grossman R, Nass D, Ram Z. Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors. Neurosurgery. 2004;55(3):562–8. https://doi.org/10.1227/01.NEU.0000134383.27713.9A.
Article
PubMed
Google Scholar
Berghoff AS, Ricken G, Widhalm G, Rajky O, Dieckmann K, Birner P, et al. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases. Histopathology. 2015;66(2):289–99. https://doi.org/10.1111/his.12537.
Article
PubMed
Google Scholar
Berghoff AS, Ricken G, Wilhelm D, Rajky O, Widhalm G, Dieckmann K, et al. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC). J Neuro-Oncol. 2016;130(1):19–29. https://doi.org/10.1007/s11060-016-2216-8.
Article
CAS
Google Scholar
Maraskovsky E, Chen WF, Shortman K. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol. 1989;143:1210–4.
CAS
PubMed
Google Scholar
Wilson KC, Center DM, Cruikshank WW. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors. 2004;22(2):97–104. https://doi.org/10.1080/08977190410001704679.
Article
CAS
PubMed
Google Scholar
Richmond J, Tuzova M, Cruikshank W, Center D. Regulation of cellular processes by interleukin-16 in homeostasis and cancer. J Cell Physiol. 2014;229(2):139–47. https://doi.org/10.1002/jcp.24441.
Article
CAS
PubMed
Google Scholar
Mathy NL, Scheuer W, Lanzendörfer M, Honold K, Ambrosius D, Norley S, et al. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology. 2000;100(1):63–9. https://doi.org/10.1046/j.1365-2567.2000.00997.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liebrich M, Guo LH, Schluesener HJ, Schwab JM, Dietz K, Will BE, et al. Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp. 2007;55(1):41–7. https://doi.org/10.1007/s00005-007-0003-0.
Article
CAS
Google Scholar
Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual faces of IFNγ in Cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity. Clin Cancer Res. 2016;22(10):2329–34. https://doi.org/10.1158/1078-0432.CCR-16-0224.
Article
CAS
PubMed
Google Scholar
Mittal SK, Roche PA. Suppression of antigen presentation by IL-10. Curr Opin Immunol. 2015;34:22–7. https://doi.org/10.1016/j.coi.2014.12.009.
Article
CAS
PubMed
PubMed Central
Google Scholar
Avdic S, Cao JZ, McSharry BP, Clancy LE, Brown R, Steain M, et al. Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J Virol. 2013;87(18):10273–82. https://doi.org/10.1128/JVI.00912-13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Qi L, Yu H, Zhang Y, Zhao D, Lv P, Zhong Y, et al. IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma. Oncotarget. 2016;7(44):71673–85. https://doi.org/10.18632/oncotarget.12317.
Article
PubMed
PubMed Central
Google Scholar
Yeung YT, McDonald KL, Grewal T, Munoz L. Interleukins in glioblastoma pathophysiology: implications for therapy. Br J Pharmacol. 2013;168(3):591–606. https://doi.org/10.1111/bph.12008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Griffin BD, Moynagh PN. Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells. J Biol Chem. 2006;281(15):10316–26. https://doi.org/10.1074/jbc.M509973200.
Article
CAS
PubMed
Google Scholar
Tada M, Diserens AC, Desbaillets I, Jaufeerally R, Hamou MF, Tribolet N. Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivo. J Neuroimmunol. 1994;50(2):187–94. https://doi.org/10.1016/0165-5728(94)90045-0.
Article
CAS
PubMed
Google Scholar
Joshi BH, Plautz GE, Puri RK. Interleukin-13 Receptor α Chain: A Novel Tumor-associated Transmembrane Protein in Primary Explants of Human Malignant Gliomas. Cancer Res. 2000;60:1168–72.
CAS
PubMed
Google Scholar
Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med. 2016;375(26):2561–9. https://doi.org/10.1056/NEJMoa1610497.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–40. https://doi.org/10.1002/jcp.26429.
Article
CAS
PubMed
Google Scholar
Ying S, Meng Q, Barata LT, Robinson DS, Durham SR, Kay AB. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol. 1997;158:5050–7.
CAS
PubMed
Google Scholar
Lu-Emerson C, Duda DG, Emblem KE, Taylor JW, Gerstner ER, Loeffler JS, et al. Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. J Clin Oncol. 2015;33(10):1197–213. https://doi.org/10.1200/JCO.2014.55.9575.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tamura R, Tanaka T, Akasaki Y, Murayama Y, Yoshida K, Sasaki H. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications. Med Oncol. 2019;37(1):2. https://doi.org/10.1007/s12032-019-1329-2.
Article
CAS
PubMed
Google Scholar
Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, et al. Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro-oncology. 2013;15(8):1079–87. https://doi.org/10.1093/neuonc/not082.
Article
CAS
PubMed
PubMed Central
Google Scholar
Castro BA, Flanigan P, Jahangiri A, Hoffman D, Chen W, Kuang R, et al. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy. Oncogene. 2017;36(26):3749–59. https://doi.org/10.1038/onc.2017.1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tian M, Chen L, Ma L, Wang D, Shao B, Wu J, et al. Expression and prognostic significance of CCL11/CCR3 in glioblastoma. Oncotarget. 2016;7(22):32617–27. https://doi.org/10.18632/oncotarget.8958.
Article
PubMed
PubMed Central
Google Scholar
Tripathi C, Tewari BN, Kanchan RK, Baghel KS, Nautiyal N, Shrivastava R, et al. Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget. 2014;5(14):5350–68. https://doi.org/10.18632/oncotarget.2110.
Article
PubMed
PubMed Central
Google Scholar
Cai J, Zhang W, Yang P, Wang Y, Li M, Zhang C, et al. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance. PLoS One. 2015;10(5):e0126022. https://doi.org/10.1371/journal.pone.0126022.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu Y, Liao C, Liu R, Liu J, Chen Z, Zhao H, et al. IRGM promotes glioma M2 macrophage polarization through p62/TRAF6/NF-κB pathway mediated IL-8 production. Cell Biol Int. 2019;43(2):125–35. https://doi.org/10.1002/cbin.11061.
Article
CAS
PubMed
Google Scholar
Jiménez AJ, Domínguez-Pinos MD, Guerra MM, Fernández-Llebrez P, Pérez-Fígares JM. Structure and function of the ependymal barrier and diseases associated with ependyma disruption. Tissue barriers. 2014;2(1):e28426. https://doi.org/10.4161/tisb.28426.
Article
PubMed
PubMed Central
Google Scholar
Galdiero MR, Marone G, Mantovani A. Cancer inflammation and cytokines. Cold Spring Harb Perspect Biol. 2018;10(8):a028662. https://doi.org/10.1101/cshperspect.a028662.
Article
CAS
PubMed
PubMed Central
Google Scholar
Albulescu R, Codrici E, Popescu ID, Mihai S, Necula LG, Petrescu D, et al. Cytokine patterns in brain tumour progression. Mediat Inflamm. 2013;979748:1–7. https://doi.org/10.1155/2013/979748.
Article
CAS
Google Scholar
Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, et al. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI insight. 2016;1(2):e85841. https://doi.org/10.1172/jci.insight.85841.
Article
PubMed Central
Google Scholar